Shalini Sharp - 12 Jun 2026 Form 4 Insider Report for Organon & Co. (OGN)

Reporting relationship: Director
Issuer ticker: OGN
Reported as of: 12 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Jun 2026, 16:41:46 UTC
Prior SEC filing: 15 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Tarnetta V. Jones, as Attorney-in-Fact for Shalini Sharp

Key filing fact

Shalini Sharp filed Form 4 for Organon & Co. (OGN) on 15 Jun 2026.

Key facts

This page summarizes Shalini Sharp's Form 4 filing for Organon & Co. (OGN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 15 Jun 2026, 16:41.

Change

Previous filing in this sequence was filed on 15 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001377202 Primary reporting owner

Sharp Shalini

Relationship: Director
Address: C/O ORGANON & CO., 30 HUDSON STREET, FLOOR 33, JERSEY CITY
Signature: /s/ Tarnetta V. Jones, as Attorney-in-Fact for Shalini Sharp
Signature date: 15 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OGN transaction Derivative

Phantom Stock

Award

Transaction value
Shares: +17,857
Change %: +28%
Price: $13.44^*
Shares after: 81,496
Date: 12 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 17,857
Exercise price
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each phantom stock unit is an economic equivalent of one share of Organon & Co. ("Organon") common stock, or 1-for-1.

Footnote F2

Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan.

Footnote F3

Holdings include phantom stock acquired in dividend reinvestment transactions on September 11, 2025, December 11, 2025, March 12, 2026 and June 11, 2026.